Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter TNFSF15 Antikörper

TNFSF15 Reaktivität: Human IHC (f) Wirt: Kaninchen Monoclonal VEGI-2052R unconjugated Recombinant Antibody
Produktnummer ABIN6938630
  • Target Alle TNFSF15 Antikörper anzeigen
    TNFSF15 (Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15))
    Antikörpertyp
    Recombinant Antibody
    Reaktivität
    • 88
    • 39
    • 17
    • 6
    • 5
    • 5
    • 5
    Human
    Wirt
    • 66
    • 24
    • 1
    Kaninchen
    Klonalität
    • 63
    • 27
    • 2
    Monoklonal
    Konjugat
    • 48
    • 6
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser TNFSF15 Antikörper ist unkonjugiert
    Applikation
    • 68
    • 30
    • 26
    • 25
    • 15
    • 13
    • 13
    • 7
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
    Spezifität
    VEGI is an anti-angiogenic cytokine that belongs to tumor necrosis factor superfamily, member 15 (TNFSF15). This protein is abundantly expressed in endothelial cells, but is not expressed in either B or T cells. The expression of this protein is inducible by TNF and IL-1 alpha. This cytokine is a ligand for receptor TNFRSF25 and decoy receptor TNFRSF21/DR6. It can activate NF-kappaB and MAP kinases, and acts as an autocrine factor to induce apoptosis in endothelial cells. This cytokine is also found to inhibit endothelial cell proliferation, and thus may function as an angiogenesis inhibitor. Reduced expression of VEGI has been reported as a marker of poor prognosis in breast cancer.
    Kreuzreaktivität (Details)
    Human.
    Aufreinigung
    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
    Immunogen
    Recombinant full-length human VEGI protein
    Klon
    VEGI-2052R
    Isotyp
    IgG
    Top Product
    Discover our top product TNFSF15 Primärantikörper
  • Applikationshinweise

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Endothelial cells. Colon, intestine, placenta, lung, liver, kidney, pancreas, spleen or prostate.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1.0 mg/mL
    Buffer
    Prepared in 10 mM PBS, WITHOUT BSA and Azide.
    Konservierungsmittel
    Azide free
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
    Haltbarkeit
    24 months
  • Target
    TNFSF15 (Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15))
    Andere Bezeichnung
    TNFSF15 (TNFSF15 Produkte)
    Synonyme
    TTPAL antikoerper, TL1 antikoerper, TL1A antikoerper, VEGI antikoerper, VEGI192A antikoerper, Tl1 antikoerper, Tl1a antikoerper, Vegi antikoerper, tumor necrosis factor superfamily member 15 antikoerper, TNF superfamily member 15 antikoerper, tumor necrosis factor (ligand) superfamily, member 15 antikoerper, TNFSF15 antikoerper, Tnfsf15 antikoerper
    Hintergrund
    TNF ligand-related molecule 1 (TL1A), Tumor necrosis factor (ligand) superfamily member 15 (TNFSF15), Vascular endothelial growth inhibitor 192a, Vascular endothelial growth inhibitor (VEGI), VEGI192A,TNFS15 / VEGI (Vascular Endothelial Growth Inhibitor)
    Cellular localisation: Secreted and Cell Surface
    Molekulargewicht
    22kDa
    Gen-ID
    9966, 241382
    UniProt
    O95150
    Pathways
    Positive Regulation of Endopeptidase Activity, Autophagie
Sie sind hier:
Kundenservice